Showing results (471-480 of 760) with videos related to
Sort By:
Pageof 76
Blood|November 9, 2002
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applicationsNicholas Mitsiades, Constantine S Mitsiades, Paul G Richardson, et al.American Journal of Hematology|June 2, 2011
A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myelomaIrene M Ghobrial, Nikhil C Munshi, Brianna N Harris, et al.Molecular Cancer Therapeutics|January 17, 2012
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myelomaDouglas W McMillin, Hannah M Jacobs, Jake E Delmore, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 ExpressionLijie Xing, Su Wang, Jiye Liu, et al.Blood Cancer Journal|February 3, 2023
Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeuticsDaisuke Ogiya, Zuzana Chyra, Sigitas J Verselis, et al.Cancer Cell|October 6, 2009
Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic targetDharminder Chauhan, Ajita V Singh, Mohan Brahmandam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myelomaClaire Fabre, Naoya Mimura, Kathryn Bobb, et al.Blood|January 24, 2012
Novel myeloma-associated antigens revealed in the context of syngeneic hematopoietic stem cell transplantationMelinda A Biernacki, Yu-tzu Tai, Guang Lan Zhang, et al.Blood|May 7, 2009
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myelomaMariateresa Fulciniti, Pierfrancesco Tassone, Teru Hideshima, et al.Clinical Lymphoma, Myeloma & Leukemia|July 29, 2014
Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory CommitteeNoopur Raje, Beth Faiman, R Donald Harvey, et al.Pageof 76